Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68

Liang Sun; Adam Meijer; Mathy Froeyen; Linlin Zhang; Hendrik Jan Thibaut; Jim Baggen; Shyla George; John Vernachio; Frank J M van Kuppeveld; Pieter Leyssen; Rolf Hilgenfeld; Johan Neyts; Leen Delang

doi:10.1128/AAC.01375-15

Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68

Liang Sun, Adam Meijer, Mathy Froeyen, Linlin Zhang, Hendrik Jan Thibaut, Jim Baggen, Shyla George, John Vernachio, Frank J M van Kuppeveld, Pieter Leyssen, Rolf Hilgenfeld, Johan Neyts, Leen Delang

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The susceptibility of ten EV-68 isolates (belonging to cluster A, B and C) to (entero-)virus inhibitors with different mechanisms of action was investigated. The 3C-protease inhibitors proved to be more efficient than enviroxime and pleconaril, which in turn were more effective than vapendavir and pirodavir. Favipiravir proved a weak inhibitor. Resistance to pleconaril maps to V69A in VP1 and resistance to rupintrivir to V104I in the 3C protease. A structural explanation is provided why both mutations may cause resistance.

Original language	English
Pages (from-to)	7782-7785
Journal	Antimicrobial Agents and Chemotherapy
Volume	59
Issue number	12
DOIs	https://doi.org/10.1128/AAC.01375-15
Publication status	Published - 14 Sept 2015

Bibliographical note

Access to Document

10.1128/AAC.01375-15

Antimicrobial Agents and Chemotherapy-2015-Sun-7782.fullFinal published version, 551 KB

Cite this

Sun, L., Meijer, A., Froeyen, M., Zhang, L., Thibaut, H. J., Baggen, J., George, S., Vernachio, J., van Kuppeveld, F. J. M., Leyssen, P., Hilgenfeld, R., Neyts, J., & Delang, L. (2015). Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68. Antimicrobial Agents and Chemotherapy, 59(12), 7782-7785. https://doi.org/10.1128/AAC.01375-15

@article{fea3fb31cdf04ebda1777ec6b6fc1d3f,

title = "Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68",

abstract = "The susceptibility of ten EV-68 isolates (belonging to cluster A, B and C) to (entero-)virus inhibitors with different mechanisms of action was investigated. The 3C-protease inhibitors proved to be more efficient than enviroxime and pleconaril, which in turn were more effective than vapendavir and pirodavir. Favipiravir proved a weak inhibitor. Resistance to pleconaril maps to V69A in VP1 and resistance to rupintrivir to V104I in the 3C protease. A structural explanation is provided why both mutations may cause resistance.",

author = "Liang Sun and Adam Meijer and Mathy Froeyen and Linlin Zhang and Thibaut, {Hendrik Jan} and Jim Baggen and Shyla George and John Vernachio and {van Kuppeveld}, {Frank J M} and Pieter Leyssen and Rolf Hilgenfeld and Johan Neyts and Leen Delang",

year = "2015",

month = sep,

day = "14",

doi = "10.1128/AAC.01375-15",

language = "English",

volume = "59",

pages = "7782--7785",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "12",

}

Sun, L, Meijer, A, Froeyen, M, Zhang, L, Thibaut, HJ, Baggen, J, George, S, Vernachio, J, van Kuppeveld, FJM, Leyssen, P, Hilgenfeld, R, Neyts, J & Delang, L 2015, 'Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68', Antimicrobial Agents and Chemotherapy, vol. 59, no. 12, pp. 7782-7785. https://doi.org/10.1128/AAC.01375-15

TY - JOUR

T1 - Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68

AU - Sun, Liang

AU - Meijer, Adam

AU - Froeyen, Mathy

AU - Zhang, Linlin

AU - Thibaut, Hendrik Jan

AU - Baggen, Jim

AU - George, Shyla

AU - Vernachio, John

AU - van Kuppeveld, Frank J M

AU - Leyssen, Pieter

AU - Hilgenfeld, Rolf

AU - Neyts, Johan

AU - Delang, Leen

PY - 2015/9/14

Y1 - 2015/9/14

N2 - The susceptibility of ten EV-68 isolates (belonging to cluster A, B and C) to (entero-)virus inhibitors with different mechanisms of action was investigated. The 3C-protease inhibitors proved to be more efficient than enviroxime and pleconaril, which in turn were more effective than vapendavir and pirodavir. Favipiravir proved a weak inhibitor. Resistance to pleconaril maps to V69A in VP1 and resistance to rupintrivir to V104I in the 3C protease. A structural explanation is provided why both mutations may cause resistance.

AB - The susceptibility of ten EV-68 isolates (belonging to cluster A, B and C) to (entero-)virus inhibitors with different mechanisms of action was investigated. The 3C-protease inhibitors proved to be more efficient than enviroxime and pleconaril, which in turn were more effective than vapendavir and pirodavir. Favipiravir proved a weak inhibitor. Resistance to pleconaril maps to V69A in VP1 and resistance to rupintrivir to V104I in the 3C protease. A structural explanation is provided why both mutations may cause resistance.

U2 - 10.1128/AAC.01375-15

DO - 10.1128/AAC.01375-15

M3 - Article

C2 - 26369972

SN - 0066-4804

VL - 59

SP - 7782

EP - 7785

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 12

ER -

Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this